Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 369 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Polyzos, Stergios A [Clear All Filters]
Helicobacter pylori-related metabolic syndrome as predictor of progression to esophageal carcinoma in a subpopulation-based Barrett's esophagus cohort..
Gastrointest Endosc. 85(2), 462-463.
(2017). Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis..
Free Radic Res. 51(1), 73-79.
(2017). The intriguing connections of leptin to hyperparathyroidism..
Endocrine. 57(3), 376-387.
(2017). Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications..
Metabolism. 72, A4-A10.
(2017). Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity..
Metabolism. 71, 198-201.
(2017). Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system..
Med Hypotheses. 102, 33-36.
(2017). Obesity and the nervous system: more questions..
Lancet Neurol. 16(10), 772-773.
(2017). Periostin and sclerostin levels in juvenile Paget's disease..
Clin Cases Miner Bone Metab. 14(2), 269-271.
(2017).
(2017). Activin A and follistatin in patients with nonalcoholic fatty liver disease..
Metabolism. 65(10), 1550-8.
(2016). Adipokines in nonalcoholic fatty liver disease..
Metabolism. 65(8), 1062-79.
(2016). Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review..
Metabolism. 65(9), 1297-306.
(2016). Circulating follistatin displays a day-night rhythm and is associated with muscle mass and circulating leptin levels in healthy, young humans..
Metabolism. 65(10), 1459-65.
(2016). Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis..
Diabetologia. 59(1), 30-43.
(2016). Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Clinical vertebral fractures following denosumab discontinuation..
Endocrine. 54(1), 271-272.
(2016). Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation..
Med Hypotheses. 95, 34.
(2016). Emerging and future therapies for nonalcoholic steatohepatitis in adults..
Expert Opin Pharmacother. 17(14), 1937-46.
(2016). Fetuin-A levels and free leptin index are reduced in patients with chronic lymphocytic leukemia: a hospital-based case-control study..
Leuk Lymphoma. 57(3), 577-84.
(2016). Helicobacter pylori infection and oesophageal adenocarcinoma..
Cancer Epidemiol. 42, 206-7.
(2016). Homocysteine in nonalcoholic steatohepatitis: A reply..
Eur J Intern Med. 35, e40-e41.
(2016). Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid..
J Clin Endocrinol Metab. 101(9), L89-90.
(2016). Nonalcoholic fatty future disease..
Metabolism. 65(8), 1007-16.
(2016). Periostin on the road to nonalcoholic fatty liver disease..
Endocrine. 51(1), 4-6.
(2016).